Director/PDMR Shareholding


 

TIDMCRYO 
 
RNS Number : 2438J 
Cryo-Save Group NV 
26 March 2010 
 

26 March 2010 
 
Cryo-Save Group N.V. 
 
Director/PDMR Shareholding 
 
Cryo-Save Group N.V., Europe's leading stem cell bank, has been informed that on 
25 March 2010 Marc Waeterschoot, Chief Executive Officer, transferred 100,000 
ordinary shares of Euro 0.10 ('Ordinary Shares') from Life-Sciences N.V., a 
company controlled by him, into his personal Cryo-Save holdings. 
 
As a result of the transaction, Marc Waeterschoot's beneficial interest in 
Cryo-Save remains unchanged at 1,792,704 Ordinary Shares, representing 
approximately 19.41% of the Company's issued share capital. 
 
 
+------------------------------+----------------------------+ 
| Enquiries:                   |                            | 
+------------------------------+----------------------------+ 
|                              |                            | 
+------------------------------+----------------------------+ 
| Cryo-Save Group              | +                          | 
|                              | 31 (0)575 548998           | 
+------------------------------+----------------------------+ 
| Marc Waeterschoot, Chief     |                            | 
| Executive                    |                            | 
+------------------------------+----------------------------+ 
| Arnoud van Tulder, Chief     |                            | 
| Financial Officer            |                            | 
+------------------------------+----------------------------+ 
|                              |                            | 
+------------------------------+----------------------------+ 
| Daniel Stewart & Company plc | +                          | 
|                              | 44 (0) 20 7776 6550        | 
+------------------------------+----------------------------+ 
| Simon Leathers / Emma Earl   |                            | 
+------------------------------+----------------------------+ 
|                              |                            | 
+------------------------------+----------------------------+ 
| College Hill (UK)            | +                          | 
|                              | 44 (0) 20 7457 2020        | 
+------------------------------+----------------------------+ 
| Adrian Duffield/Rozi Morris  |                            | 
+------------------------------+----------------------------+ 
 
SPJ Financiële Communicatie Amstelveen (Netherlands) + 31 (0)206478181 
Kees Jongsma/Leon Melens 
 
About Cryo-Save 
 
With more than 120,000 samples saved, Cryo-Save is the leading stem cell bank in 
Europe and one of the fastest growing in the world. Driven by its international 
business strategy, Cryo-Save is now represented in 38 countries on three 
continents and has state-of-the-art processing facilities in Belgium, Germany, 
Dubai, India and France (under construction). 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSLIFETVTIRFII

Cryo-Save (LSE:CRYO)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025